RESUMEN
Infectious diseases have the potential to extirpate populations of great apes. As the interface between humans and great apes expands, zoonoses pose an increasingly severe threat to already endangered great ape populations. Despite recognition of the threat posed by human pathogens to great apes, health monitoring is only conducted for a small fraction of the world's wild great apes (and mostly those that are habituated) meaning that outbreaks of disease often go unrecognized and therefore unmitigated. This lack of surveillance (even in sites where capacity to conduct surveillance is present) is the most significant limiting factor in our ability to quickly detect and respond to emerging infectious diseases in great apes when they first appear. Accordingly, we must create a surveillance system that links disease outbreaks in humans and great apes in time and space, and enables veterinarians, clinicians, conservation managers, national decision makers, and the global health community to respond quickly to these events. Here, we review existing great ape health surveillance programs in African range habitats to identify successes, gaps, and challenges. We use these findings to argue that standardization of surveillance across sites and geographic scales, that monitors primate health in real-time and generates early warnings of disease outbreaks, is an efficient, low-cost step to conserve great ape populations. Such a surveillance program, which we call "Great Ape Health Watch" would lead to long-term improvements in outbreak preparedness, prevention, detection, and response, while generating valuable data for epidemiological research and sustainable conservation planning. Standardized monitoring of great apes would also make it easier to integrate with human surveillance activities. This approach would empower local stakeholders to link wildlife and human health, allowing for near real-time, bidirectional surveillance at the great ape-human interface.
Asunto(s)
Enfermedades del Simio Antropoideo , Enfermedades Transmisibles Emergentes , Hominidae , Animales , Animales Salvajes , Enfermedades del Simio Antropoideo/epidemiología , Enfermedades del Simio Antropoideo/prevención & control , Enfermedades Transmisibles Emergentes/epidemiología , Enfermedades Transmisibles Emergentes/prevención & control , Enfermedades Transmisibles Emergentes/veterinaria , Brotes de Enfermedades/prevención & control , Brotes de Enfermedades/veterinaria , Zoonosis/epidemiología , Zoonosis/prevención & controlRESUMEN
The world's 1063 mountain gorillas (Gorilla beringei beringei) live in two subpopulations at the borders of the Democratic Republic of Congo, Rwanda, and Uganda. The majority of mountain gorillas are human-habituated to facilitate tourism and research, which brings mountain gorillas into close proximity of people daily. Wild great apes are proven to be susceptible to human pathogens, including viruses that have caused fatal respiratory disease in mountain gorillas (e.g., human metapneumovirus1 ). This is the result of the close genetic relatedness of humans and gorillas as species, and the structural and genetic similarity in molecular receptors that allow viruses to infect cells2 . At the time of writing, there is no evidence that severe acute respiratory syndrome coronavirus 2, the coronavirus that causes coronavirus disease 19 (COVID-19), has infected a mountain gorilla. However, due to the significant potential for human-to-gorilla transmission, mountain gorilla range States took immediate steps to minimize the COVID-19 threat. These actions included a combination of preventive practice around gorillas and other great apes (e.g., mandatory face mask use, increased "social" minimum distancing from gorillas) as well as human public health measures (e.g., daily health/fever screenings, COVID-19 screening, and quarantines). Minimization of the COVID-19 threat also required socioeconomic decision-making and political will, as all gorilla tourism was suspended by late March 2020 and guidelines developed for tourism reopening. A consortium that collaborates and coordinates on mountain gorilla management and conservation, working within an intergovernmental institutional framework, took a multifaceted One Health approach to address the COVID-19 threat to mountain gorillas by developing a phased contingency plan for prevention and response. The aim of this paper is to describe how range States and partners achieved this collaborative planning effort, with intent that this real-world experience will inform similar actions at other great ape sites.
Asunto(s)
Enfermedades del Simio Antropoideo , COVID-19 , Hominidae , Salud Única , Virus , Animales , Enfermedades del Simio Antropoideo/epidemiología , Enfermedades del Simio Antropoideo/prevención & control , COVID-19/epidemiología , COVID-19/prevención & control , Gorilla gorilla , Humanos , Pandemias/prevención & controlAsunto(s)
Enfermedades del Simio Antropoideo/prevención & control , Enfermedades del Simio Antropoideo/virología , Infecciones por Coronavirus/prevención & control , Infecciones por Coronavirus/veterinaria , Pandemias/prevención & control , Pandemias/veterinaria , Neumonía Viral/prevención & control , Neumonía Viral/veterinaria , Animales , COVID-19 , HominidaeRESUMEN
Despite the growing knowledge and literature on primate medicine, assessment and treatment of behavioral abnormalities in nonhuman primates (NHPs) is an underdeveloped field. There is ample evidence for similarity between humans and great apes, including basic neurologic physiology and emotional processes, and no substantial argument exists against a concept of continuity for abnormal conditions in NHPs that emerge in response to adverse experiences, akin to human psychopathology. NHPs have served as models for human psychopathologies for many decades, but the acquired knowledge has only hesitantly been applied to primates themselves. This review aims to raise awareness among the veterinary community of the wealth of literature on NHP psychopathologies in human medicine and anthropology literature and calls for the necessity to include mental health assessments and professionally structured treatment approaches in NHP medicine. Growing understanding about causes and pathogenesis of abnormal behavior in NHP will not only help to prevent the development of undesirable behaviors but also allow for treatment and management of long-lived, already affected animal patients.
Asunto(s)
Enfermedades del Simio Antropoideo/diagnóstico , Enfermedades del Simio Antropoideo/prevención & control , Trastornos Mentales/veterinaria , Enfermedades de los Monos/diagnóstico , Enfermedades de los Monos/prevención & control , Primates , Animales , Enfermedades del Simio Antropoideo/psicología , Trastornos Mentales/diagnóstico , Trastornos Mentales/psicología , Trastornos Mentales/terapia , Enfermedades de los Monos/psicología , Primates/psicología , PsicopatologíaRESUMEN
Due to their genetic relatedness, great apes are highly susceptible to common human respiratory pathogens. Although most respiratory pathogens, such as human respiratory syncytial virus (HRSV) and human metapneumovirus (HMPV), rarely cause severe disease in healthy human adults, they are associated with considerable morbidity and mortality in wild great apes habituated to humans for research or tourism. To prevent pathogen transmission, most great ape projects have established a set of hygiene measures ranging from keeping a specific distance, to the use of surgical masks and establishment of quarantines. This study investigates the incidence of respiratory symptoms and human respiratory viruses in humans at a human-great ape interface, the Taï Chimpanzee Project (TCP) in Côte d'Ivoire, and consequently, the effectiveness of a 5-day quarantine designed to reduce the risk of potential exposure to human respiratory pathogens. To assess the impact of quarantine as a preventative measure, we monitored the quarantine process and tested 262 throat swabs for respiratory viruses, collected during quarantine over a period of 1 year. Although only 1 subject tested positive for a respiratory virus (HRSV), 17 subjects developed symptoms of infection while in quarantine and were subsequently kept from approaching the chimpanzees, preventing potential exposure in 18 cases. Our results suggest that quarantine-in combination with monitoring for symptoms-is effective in reducing the risk of potential pathogen exposure. This research contributes to our understanding of how endangered great apes can be protected from human-borne infectious disease.
Asunto(s)
Enfermedades del Simio Antropoideo/prevención & control , Pan troglodytes , Cuarentena/métodos , Infecciones del Sistema Respiratorio/virología , Animales , Enfermedades del Simio Antropoideo/transmisión , Enfermedades del Simio Antropoideo/virología , Côte d'Ivoire/epidemiología , Humanos , Infecciones por Virus Sincitial Respiratorio/prevención & control , Infecciones por Virus Sincitial Respiratorio/veterinaria , Virus Sincitial Respiratorio Humano/aislamiento & purificaciónRESUMEN
"Ecosystem Health recognizes the inherent interdependence of the health of humans, animals and ecosystems and explores the perspectives, theories and methodologies emerging at the interface between ecological and health sciences." This broad focus requires new approaches and methods for solving problems of greater complexity at larger scales than ever before. Nowhere is this point more salient than the case of disease emergence and control at the human-non human primate interface in shrinking tropical forests under great anthropogenic pressure. This special edition brings together transdisciplinary experts who have created successful partnerships leading to advances in ecosystem approaches to health for wild ape populations with relevance to all developing country tropical forest environments. It is no coincidence that the advances herein highlight two long term health projects-the Gombe Ecosystem Health Project (Gombe National Park, Tanzania), and the Taï Chimpanzee Project (TCP) in Côte d'Ivoire-since standardizing and validating noninvasive disease surveillance, risk assessment and management methods presents a special series of challenges where time is a major factor. Advances highlighted in this addition include: health surveillance and monitoring, health risk analysis, field immobilization and interventions, human-NHP networks/interfaces, diagnostic tool development, and cutting edge molecular and genetic techniques.
Asunto(s)
Enfermedades del Simio Antropoideo/prevención & control , Conservación de los Recursos Naturales , Hominidae , Animales , Côte d'Ivoire , Ecosistema , Monitoreo Epidemiológico/veterinaria , TanzaníaRESUMEN
Hepatitis B virus causes horizontally transmitted infectious hepatopathy of primates and may progress to hepatocellular carcinoma. Historically, a small number of chimpanzees ( Pan troglodytes ) living in accredited North American zoos have been confirmed with positive hepatitis B serology consistent with exposure. However, the overall status for this population and the interpretation of these individual test results have not been established previously. The current U.S. zoo-housed population (n = 259) was assessed serologically for hepatitis B by surface protein antigen (HbsAg) and surface antibodies (anti-Hbs). Signalment, origin, current health status, history of liver disease, and hepatitis B vaccination history were obtained for each animal. Serologic status was measured directly in 86.5% (n = 224) of these individuals, with 2.2% (n = 5) of the study population determined to be chronically infected by positive HbsAg and negative anti-Hbs status. Additionally, 11.6% (n = 26) of the directly measured population tested were HbsAg negative and anti-Hbs positive, which was indicative of viral exposure. No animals were determined to be acutely infected as HbsAg and anti-Hbs positive. Although these results demonstrated a relatively low prevalence of hepatitis B infection among these chimpanzees, the varied serologic results between institutions underscored the importance of routine serologic testing, especially at times of proposed transfers, and consideration of species vaccination protocols.
Asunto(s)
Enfermedades del Simio Antropoideo/virología , Hepatitis B/veterinaria , Pan troglodytes , Animales , Animales de Zoológico , Enfermedades del Simio Antropoideo/epidemiología , Enfermedades del Simio Antropoideo/prevención & control , Hepatitis B/epidemiología , Hepatitis B/prevención & control , Antígenos de Superficie de la Hepatitis B , Propiedad , Estados Unidos/epidemiologíaRESUMEN
The importance of neutralizing antibodies (NAbs) in protection against hepatitis C virus (HCV) remains controversial. We infused a chimpanzee with H06 immunoglobulin from a genotype 1a HCV-infected patient and challenged with genotype strains efficiently neutralized by H06 in vitro. Genotype 1a NAbs afforded no protection against genotype 4a or 5a. Protection against homologous 1a lasted 18 weeks, but infection emerged when NAb titers waned. However, 6a infection was prevented. The differential in vivo neutralization patterns have implications for HCV vaccine development.
Asunto(s)
Anticuerpos Neutralizantes/uso terapéutico , Hepacivirus/inmunología , Anticuerpos contra la Hepatitis C/uso terapéutico , Inmunoglobulinas/uso terapéutico , Vacunas contra Hepatitis Viral/uso terapéutico , Animales , Anticuerpos Neutralizantes/inmunología , Enfermedades del Simio Antropoideo/inmunología , Enfermedades del Simio Antropoideo/prevención & control , Reacciones Cruzadas/inmunología , Genotipo , Anticuerpos contra la Hepatitis C/inmunología , Humanos , Inmunización Pasiva , Inmunoglobulinas/inmunología , Pan troglodytes/virología , Vacunas contra Hepatitis Viral/inmunologíaRESUMEN
A 40-yr-old male captive chimpanzee (Pan troglodytes) presented with depression and anorexia for 7 days. The tentative diagnosis, following a physical examination under anesthesia, was pneumonia with sepsis. Despite antibiotic treatment and supportive care the chimpanzee died a week following presentation. Gross pathology confirmed severe purulent pneumonia and diffuse hepatosplenic abscesses. Detected in serum at the time of the initial examination, the melioidosis serum antibody titer was elevated (> 1:512). Soil samples were collected from three sites in the exhibit at three depths of 5, 15, and 30 cm. By direct and enrichment culture, positive cultures for Burkholderia pseudomallei were found at 5 and 15 cm in one site. The other two sites were positive by enrichment culture at the depth of 5 cm. To prevent disease in the remaining seven troop members, they were relocated to permit a soil treatment with calcium oxide. The exhibit remained empty for approximately 1 yr before the chimpanzees were returned. During that period, the soil in the exhibit area was again cultured as before and all samples were negative for B. pseudomallei. Following the soil treatment in the exhibit, all chimpanzees have remained free of clinical signs consistent with melioidosis.
Asunto(s)
Crianza de Animales Domésticos , Enfermedades del Simio Antropoideo/patología , Melioidosis/veterinaria , Pan troglodytes , Animales , Animales de Zoológico , Enfermedades del Simio Antropoideo/prevención & control , Burkholderia mallei , Desinfección , Resultado Fatal , Masculino , Melioidosis/patología , Microbiología del SueloAsunto(s)
Anestesia/veterinaria , Pan troglodytes , Medicina Veterinaria/métodos , Anestesia/métodos , Animales , Animales Salvajes , Enfermedades del Simio Antropoideo/prevención & control , Enfermedades del Simio Antropoideo/terapia , Humanos , Sierra Leona , Drogas Veterinarias/economía , Drogas Veterinarias/provisión & distribuciónRESUMEN
Disease is a major concern for the conservation of great apes, and one that is likely to become increasingly relevant as deforestation and the rise of ecotourism bring humans and apes into ever closer proximity. Consequently, it is imperative that preventative measures are explored to ensure that future epidemics do not wipe out the remaining populations of these animals. In this paper, social network analysis was used to investigate vulnerability to disease in a population of wild orang-utans and a community of wild chimpanzees. Potential 'superspreaders' of disease--individuals with disproportionately central positions in the community or population--were identified, and the efficacy of vaccinating these individuals assessed using simulations. Three resident female orang-utans were identified as potential superspreaders, and females and unflanged males were predicted to be more influential in disease spread than flanged males. By contrast, no superspreaders were identified in the chimpanzee network, although males were significantly more central than females. In both species, simulating the vaccination of the most central individuals in the network caused a greater reduction in potential disease pathways than removing random individuals, but this effect was considerably more pronounced for orang-utans. This suggests that targeted vaccinations would have a greater impact on reducing disease spread among orang-utans than chimpanzees. Overall, these results have important implications for orang-utan and chimpanzee conservation and highlight the role that certain individuals may play in the spread of disease and its prevention by vaccination.
Asunto(s)
Enfermedades del Simio Antropoideo , Modelos Biológicos , Pan troglodytes , Pongo abelii , Vacunación , Animales , Enfermedades del Simio Antropoideo/epidemiología , Enfermedades del Simio Antropoideo/prevención & control , Enfermedades del Simio Antropoideo/transmisión , Femenino , Masculino , Factores SexualesRESUMEN
BACKGROUND: To understand immunological responses in chimpanzees vaccinated with live-attenuated vaccine (oral polio vaccine; OPV), serum neutralizing antibodies against poliovirus types 1, 2, and 3 were investigated over time. METHODS: The neutralizing antibody titers against poliovirus types 1, 2, and 3 were determined by microneutralization test using 100 ID(50) of poliovirus types 1, 2, and 3 (Sabin strains). RESULTS: Neutralizing antibodies against poliovirus types 1, 2, and 3 were detected in 85.7%, 71.4%, and 65% of the serum from 42 chimpanzees tested 9 years post-vaccination. The neutralizing antibody titers in chimpanzees were similar to the documented levels in human studies as an indicator of vaccine efficacy. CONCLUSIONS: This study reveals persistence of neutralizing antibodies in chimpanzees for at least 9 years after vaccination with OPV. This first study in chimpanzees provides useful information for the evaluation of the success of vaccination with OPV in other captive apes.
Asunto(s)
Enfermedades del Simio Antropoideo/prevención & control , Pan troglodytes/inmunología , Poliomielitis/veterinaria , Vacuna Antipolio Oral/inmunología , Poliovirus/inmunología , Vacunación/veterinaria , Animales , Anticuerpos Neutralizantes/sangre , Anticuerpos Antivirales/sangre , Enfermedades del Simio Antropoideo/inmunología , Enfermedades del Simio Antropoideo/virología , Femenino , Masculino , Pruebas de Neutralización/veterinaria , Poliomielitis/inmunología , Poliomielitis/prevención & control , Poliomielitis/virología , Vacuna Antipolio Oral/administración & dosificación , UgandaAsunto(s)
Enfermedades del Simio Antropoideo/transmisión , Brotes de Enfermedades/veterinaria , Infecciones por Paramyxoviridae/veterinaria , Animales , Animales Salvajes , Enfermedades del Simio Antropoideo/prevención & control , Control de Enfermedades Transmisibles/métodos , Conservación de los Recursos Naturales , Hominidae , Humanos , Metapneumovirus/aislamiento & purificación , Infecciones por Paramyxoviridae/transmisión , Infecciones por Paramyxoviridae/virología , Virus Sincitiales Respiratorios/aislamiento & purificaciónAsunto(s)
Conservación de los Recursos Naturales , Pan troglodytes , Animales , Enfermedades del Simio Antropoideo/prevención & control , Control de Enfermedades Transmisibles/métodos , Brotes de Enfermedades/veterinaria , Humanos , Incidencia , Dinámica Poblacional , Factores de Riesgo , Tanzanía/epidemiología , Factores de TiempoAsunto(s)
Enfermedades del Simio Antropoideo/prevención & control , Enfermedades del Simio Antropoideo/transmisión , Ecosistema , Gorilla gorilla , Enfermedades Respiratorias/veterinaria , Animales , Control de Enfermedades Transmisibles/métodos , Conservación de los Recursos Naturales/métodos , Humanos , Enfermedades Respiratorias/prevención & controlAsunto(s)
Enfermedades del Simio Antropoideo/prevención & control , Conservación de los Recursos Naturales , Pan troglodytes , Enfermedades Respiratorias/veterinaria , Animales , Enfermedades del Simio Antropoideo/epidemiología , Enfermedades del Simio Antropoideo/virología , Conducta Animal , Control de Enfermedades Transmisibles/métodos , Brotes de Enfermedades/veterinaria , Enfermedades Respiratorias/epidemiología , Enfermedades Respiratorias/prevención & control , Enfermedades Respiratorias/virología , Tanzanía/epidemiologíaAsunto(s)
Enfermedades del Simio Antropoideo/epidemiología , Brotes de Enfermedades/veterinaria , Gorilla gorilla , Fiebre Hemorrágica Ebola/veterinaria , África Central/epidemiología , Animales , Enfermedades del Simio Antropoideo/mortalidad , Enfermedades del Simio Antropoideo/prevención & control , Conservación de los Recursos Naturales , Brotes de Enfermedades/prevención & control , Vacunas contra el Virus del Ébola/administración & dosificación , Extinción Biológica , Fiebre Hemorrágica Ebola/epidemiología , Fiebre Hemorrágica Ebola/mortalidad , Fiebre Hemorrágica Ebola/prevención & control , Dinámica PoblacionalRESUMEN
Hepatitis C is a major cause of chronic liver disease, with 170 million individuals infected worldwide and no available vaccine. We analyzed the effects of an induced T-cell response in 3 chimpanzees, targeting nonstructural proteins in the absence of neutralizing antibodies. In all animals the specific T-cell response modified the outcome of infection, producing a 10- to 1,000-fold reduction in peak virus titers. The challenge of 2 immunized animals that had been previously exposed to hepatitis C virus resulted in subclinical infections. Immune responses in the third animal, naive prior to immunization, limited viral replication immediately, evidenced by a 30-fold reduction in virus titer by week 2, declining to a nonquantifiable level by week 6. After 10 weeks of immunological control, we observed a resurgence of virus, followed by progression to a persistent infection. Comparing virus evolution with T-cell recognition, we demonstrated that: (i) resurgence was concomitant with the emergence of new dominant viral populations bearing single amino acid changes in the NS3 and NS5A regions, (ii) these mutations resulted in a loss of CD4+ T-cell recognition, and (iii) subsequent to viral resurgence and immune escape a large fraction of NS3-specific T cells became impaired in their ability to secrete IFN-gamma and proliferate. In contrast, NS3-specific responses were sustained in the recovered/immunized animals presenting with subclinical infections. In conclusion, viral escape from CD4+ T cells can result in the eventual failure of an induced T-cell response that initially controls infection. Vaccines that can induce strong T-cell responses prior to challenge will not necessarily prevent persistent HCV infection.